Trials / Completed
CompletedNCT00927940
RESOLUTE Japan - The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent
The Clinical Evaluation of the MDT-4107 Drug-Eluting Coronary Stent in De Novo Lesions in Native Coronary Arteries
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Medtronic Vascular · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The objective of the study is to verify the safety and efficacy of the MDT-4107 Drug-Eluting Coronary Stent for the treatment of de novo lesions in native coronary arteries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | MDT-4107 Drug Eluting Stent | Implantation of a MDT-4107 Zotarolimus-Eluting Coronary Stent |
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2010-12-01
- Completion
- 2015-02-01
- First posted
- 2009-06-25
- Last updated
- 2015-05-05
- Results posted
- 2012-07-09
Locations
14 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00927940. Inclusion in this directory is not an endorsement.